General Information of the Compound
| Compound ID |
CP0912432
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4'-((4-(4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yloxy)butyl)piperazin-1-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methylbiphenyl-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C51H61N7O8
|
||||||||||||||||||
| Molecular Weight |
900.09
|
||||||||||||||||||
| Canonical SMILES |
CCN(c1cc(-c2ccc(CN3CCN(CCCCOc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C51H61N7O8/c1-5-57(38-17-25-65-26-18-38)43-29-37(28-40(34(43)4)47(60)52-30-41-32(2)27-33(3)53-48(41)61)36-13-11-35(12-14-36)31-56-22-20-55(21-23-56)19-6-7-24-66-44-10-8-9-39-46(44)51(64)58(50(39)63)42-15-16-45(59)54-49(42)62/h8-14,27-29,38,42H,5-7,15-26,30-31H2,1-4H3,(H,52,60)(H,53,61)(H,54,59,62)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JWGHKBXAXKDEBJ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound